Barring a close below $46, we are likely to see ABT remain firm and work higher.

Intermediate Level Trade: BMY Real Money Pro($)

I prefer a bullishly biased vertical call spread.
We really want to shake out the weak hands here.

Remember the Rules of the Road Real Money Pro($)

Diversification is the only risk management strategy that will work consistently.

Advanced Trade: Pfizer Real Money Pro($)

This tactic for PFE is a rare setup for those bullish in any underlying stock.

4 Undervalued Biotech Stocks Real Money Pro($)

Two are turnaround stories, and two are oversold.

Bet With Buffett on DaVita Real Money Pro($)

Using a "buy-write combination" could pay off for this slow performing stock.
Here's where to buy NVS.
Synergy Pharmaceuticals, Trevena and Egalet seem to have worst-case scenarios priced into them.
Consider protecting your profits.

Columnist Conversations

Under Armour's founder Kevin Plank has never been one to sound weak in a public setting. Plank is known for hi...


News Breaks

Powered by


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.